MAR 24, 2016
Mechanisms of Anti-VEGF and Prospects for Future ROP Treatments
By Mary Elizabeth Hartnett, MD, FACS
AAO 2015
Pediatric Ophth/Strabismus, Vitreoretinal Diseases
In this presentation from Pediatric Ophthalmology Subspecialty Day at AAO 2015, Mary Elizabeth Hartnett, MD, discusses why anti-VEGF treatment should be considered in severe retinopathy of prematurity and the dilemma of anti-VEGF treatments in preterm infants.